Phase 1, Double-Blind, Randomized, Parallel-Group, Single-Dose, 2-Arm, Safety Study Of PF-05280014 And Trastuzumab Sourced From The US Administered To Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2014
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer; Gastric cancer
- Focus Adverse reactions
- Sponsors Pfizer
- 22 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Mar 2014 Planned End Date changed from 1 Feb 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov record.
- 18 Feb 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.